GEN Exclusives

More »

GEN News Highlights

More »
Jan 2, 2008

Merck & Co. Sells Manufacturing Facility to PRWT

  • PRWT Services is establishing a presence in the life science market through the acquisition of the Cherokee chemical manufacturing plant in Riverside, PA, from Merck & Co.

    Cherokee also entered into a five-year supply agreement with Merck for an estimated value of $100–200 million annually.
    The Cherokee plant is an API manufacturing facility of products/antibiotics for humans and animals.  The facility will be a part of subsidiary, Cherokee Pharmaceuticals.

    PRWT intends to make considerable capital investments in the Cherokee plant to support the growth of the business and increase the number of jobs available in the local community, he continues.

    “The acquisition of the Cherokee plant is consistent with PRWT’s vision of growing the company by expanding into new markets, services, and lines of business,” says Willie F. Johnson, chairman & CEO of PRWT.

    “All 400 employees working at the plant will be offered jobs and are expected to transfer their employment from Merck to PRWT,” Johnson continues.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »